Literature DB >> 23868730

[Multimorbidity in elderly rheumatic patients part 1].

H-J Lakomek1, T Brabant, M Lakomek, D Lüttje.   

Abstract

An appropriate treatment of elderly rheumatic patients implements comprehensive diagnostics and exclusion diagnostics of e.g. coronary heart disease, osteoporosis, renal failure, diabetes mellitus type 2 and thyroid gland dysfunction. Furthermore, the complex disease situation might require the integration of other faculties or might be a reason for inpatient treatment. The complexity in the treatment of multimorbid elderly patients suffering from rheumatism not only rises with increasing age but also constitutes a considerable challenge due to existing incapacities and preceding as well as currently performed immunosuppressive therapies. The necessary treatment framework is outlined from the perspective of rheumatologists and geriatricians. Typical geriatric symptoms, such as malnutrition, immobility and frailty might be enhanced if multimorbidity is simultaneously present.

Entities:  

Mesh:

Year:  2013        PMID: 23868730     DOI: 10.1007/s00393-012-1115-4

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  46 in total

Review 1.  [Care for patients in extreme old age by the internist in clinical practice].

Authors:  C Lucke; D Krause; D Lüttje
Journal:  Internist (Berl)       Date:  2000-06       Impact factor: 0.743

Review 2.  [Malnutrition in the elderly].

Authors:  M Drey; M J Kaiser
Journal:  Dtsch Med Wochenschr       Date:  2011-01-26       Impact factor: 0.628

Review 3.  TNF and bone.

Authors:  Jean-Pierre David; Georg Schett
Journal:  Curr Dir Autoimmun       Date:  2010-02-18

4.  [Do we need in-patient rheumatology?].

Authors:  H-J Lakomek
Journal:  Dtsch Med Wochenschr       Date:  2006-10-13       Impact factor: 0.628

Review 5.  Coronary artery disease and rheumatoid arthritis.

Authors:  Nicola Goodson
Journal:  Curr Opin Rheumatol       Date:  2002-03       Impact factor: 5.006

6.  Osteoclasts are essential for TNF-alpha-mediated joint destruction.

Authors:  Kurt Redlich; Silvia Hayer; Romeo Ricci; Jean-Pierre David; Makiyeh Tohidast-Akrad; George Kollias; Günter Steiner; Josef S Smolen; Erwin F Wagner; Georg Schett
Journal:  J Clin Invest       Date:  2002-11       Impact factor: 14.808

Review 7.  Systemic bone effects of biologic therapies in rheumatoid arthritis and ankylosing spondylitis.

Authors:  C B Confavreux; R D Chapurlat
Journal:  Osteoporos Int       Date:  2010-10-20       Impact factor: 4.507

8.  [Special care requirements of elderly and old people: as reflected in the new Council of Experts Report].

Authors:  A Kuhlmey
Journal:  Z Gerontol Geriatr       Date:  2009-11-13       Impact factor: 1.281

9.  The prevalence of undiagnosed thyroid disorders in a previously iodine-deficient area.

Authors:  Henry Völzke; Jan Lüdemann; Daniel M Robinson; Knut W Spieker; Christian Schwahn; Axel Kramer; Ulrich John; Wieland Meng
Journal:  Thyroid       Date:  2003-08       Impact factor: 6.568

10.  Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality.

Authors:  Nicolas Ochs; Reto Auer; Douglas C Bauer; David Nanchen; Jacobijn Gussekloo; Jacques Cornuz; Nicolas Rodondi
Journal:  Ann Intern Med       Date:  2008-05-19       Impact factor: 25.391

View more
  7 in total

Review 1.  Multimorbidity and rheumatic conditions-enhancing the concept of comorbidity.

Authors:  Helga Radner; Kazuki Yoshida; Josef S Smolen; Daniel H Solomon
Journal:  Nat Rev Rheumatol       Date:  2014-01-14       Impact factor: 20.543

Review 2.  [Promotion of physical activity for older patients with rheumatism : Characteristics of inflammatory rheumatic diseases against the background of physical activity recommendations].

Authors:  A Golla; K Mattukat; W Mau
Journal:  Z Rheumatol       Date:  2019-03       Impact factor: 1.372

3.  [Prevalence, comorbidity and interdisciplinary treatment of rheumatoid arthritis - Insurance data on outpatient and inpatient care in Baden-Württemberg].

Authors:  A Strahl; O Schneider; J Frankenhauser-Mannuß; S Knapstein; C Hermann; B Lembeck; H-M Lorenz; W Rüther; J Flechtenmacher
Journal:  Z Rheumatol       Date:  2018-03       Impact factor: 1.372

4.  [Which kind of structures and facilities are needed for the care of elderly patients with rheumatic diseases?].

Authors:  C Fiehn
Journal:  Z Rheumatol       Date:  2014-04       Impact factor: 1.372

5.  [Sarcopenia and frailty in older patients with rheumatism].

Authors:  U Lange
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

Review 6.  [Characteristics of pharmacotherapy in older patients with rheumatism].

Authors:  H-J Lakomek; Christian Schulz
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

Review 7.  [Complex treatments in rheumatology and geriatrics - Challenges - Differences - Chances].

Authors:  H-J Lakomek; W Fiori
Journal:  Z Rheumatol       Date:  2018-06       Impact factor: 1.372

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.